Filing Flows › Alpha Teknova (TKNO) › Clinical Solutions revenue
Alpha Teknova (TKNO) Clinical Solutions revenue by quarter
Alpha Teknova's Clinical Solutions revenue was $3.2M in Q3 2026 (third quarter 2026), +30% from Q2 2026. Over the last 7 quarters it ranged from $1.2M (Q1 2025) to $3.2M (Q3 2026).
| Quarter | Clinical Solutions revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $3.2M | +30% | +86% |
| Q2 2026 | $2.4M | +13% | +18% |
| Q1 2026 | $2.1M | -21% | +85% |
| Q4 2025 | $2.7M | +60% | — |
| Q3 2025 | $1.7M | -17% | — |
| Q2 2025 | $2.1M | +77% | — |
| Q1 2025 | $1.2M | — | — |
Q3 2026 at a glance
Alpha Teknova, Q3 2026: revenue $12.7M (+22% year over year), operating margin -25.2%, net loss $3.5M, operating cash flow −$1.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is Alpha Teknova's Clinical Solutions revenue?
Alpha Teknova's Clinical Solutions revenue was $3.2M in Q3 2026 (third quarter 2026), +30% from Q2 2026.
How has Alpha Teknova's Clinical Solutions revenue changed?
Over the last 7 quarters it ranged from $1.2M (Q1 2025) to $3.2M (Q3 2026).